Placenta Previa after ART

Publish Year: 1398
نوع سند: مقاله کنفرانسی
زبان: English
View: 291

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

RROYAN20_415

تاریخ نمایه سازی: 29 مهر 1398

Abstract:

Background: Placenta previa is a drastic disorders of preg-nancy with fatal maternal and neonatal outcomes.The risk of placenta previa can be enhancement in pregnancies received by assisted reproduction technology (ART).Materials and Methods: A narrative review was performed within articles published a PubMed , Elsevier , SID and original text books to reach the aim.Results: The treatment of infertility is growing speedily .The placenta has a main role in fetal health and functions as a es-sential bridge to normal fetal development among pregnancy. By reviewing studies there was a six-fold higher risk of pla-centa previa in singleton pregnancies conceived by assisted fertilization compared with naturally conceived pregnancies. In IVF treatment, the risk of placenta previa is elevated 4-fold in women with an endometrial thickness of > 12 mm against women with an endometrial thickness of <9 mm. The diagnosis is suspected using a combination of gray – scale and color flow Doppler ultrasound.Transvaginal sonography is a useful adja-cent, especially with coexistent placenta previa .Conclusion: It must be considered the couples who start the infertility treatment, spend high cost and time. They need to be awarded of the increased risk of Placenta previa after ART and must be helped on managing the pregnancy.

Authors

SH Irani

Department of Reproductive Imaging, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine,ACECR, Tehran, Iran

Z Arianfar

Department of Reproductive Imaging, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine,ACECR, Tehran, Iran

F Ahmadi

Department of Reproductive Imaging, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine,ACECR, Tehran, Iran